Carlson video thrusts AVMA telemedicine fight into public view
Bottom line
A Tucker Carlson video is amplifying a long-running fight over veterinary telemedicine, with Dutch Pet founder and CEO Joe Spector accusing the American Veterinary Medical Association of blocking virtual care and scaring veterinarians away from using it. The AVMA pushed back, saying it does not oppose telemedicine itself, but supports its use within an established veterinarian-client-patient relationship, or VCPR, and argues that the same standard of care should apply whether care is delivered in person or electronically. That distinction matters because federal law ties some prescribing, especially extralabel drug use, to a valid VCPR, and FDA guidance says that relationship must include recent examination of the animal or timely visits to the premises where the animal is kept. (thecaninereview.com)
Why it matters: For veterinary professionals, this is less about one media hit and more about a public-facing campaign to redefine telemedicine as a substitute for in-person care in more states. The policy landscape is already shifting: AAHA and AVMA guidance supports telehealth workflows inside practice, while AAVSB’s newer model regulations frame telemedicine as another mode of practice but still note that federal prescribing rules can require an in-person VCPR. That leaves clinics navigating a patchwork of state law, federal drug rules, client expectations, and growing pressure from venture-backed telehealth companies promising faster access for pet parents. (aaha.org)
What to watch: Watch for renewed state-level lobbying over virtual VCPR rules, and for whether organized veterinary groups answer this kind of consumer-facing messaging more aggressively in 2026. (paulickreport.com)
A Tucker Carlson segment featuring Dutch Pet founder Joe Spector has turned a regulatory dispute over veterinary telemedicine into a broader public attack on the AVMA, with Spector alleging the association has misrepresented the law and chilled virtual care. The AVMA’s response was narrower and more familiar: it says telemedicine can be appropriate, but only when delivered at the same professional standard as in-person care and, for patient-specific diagnosis and treatment, within a previously established veterinarian-client-patient relationship. (thecaninereview.com)
That argument has been building for years. AVMA has long described telehealth as an umbrella term and telemedicine as one tool within practice, not a replacement for hands-on veterinary care. The 2021 AAHA/AVMA telehealth guidelines outlined workflows that use telemedicine for follow-up, monitoring, and triage, but they also emphasized checking state rules on whether a VCPR can be established electronically and warned that federal requirements still apply when prescribing extralabel drugs or issuing Veterinary Feed Directives. (avma.org)
The legal friction point is the VCPR. Under FDA’s AMDUCA framework, extralabel use of approved animal or human drugs must occur within a valid VCPR, and the federal definition says that relationship exists only when the veterinarian has recently seen the animal or made medically appropriate and timely visits to the premises where the animal is kept. AAVSB’s current model regulations are somewhat more permissive in tone, describing telemedicine as a mode of practice rather than a separate category, but they also explicitly acknowledge those same federal limits around prescribing. In other words, even where states loosen virtual care rules, federal law can still constrain what a veterinarian may prescribe remotely. (fda.gov)
That’s the context missing from the more combative public narrative. Dutch’s own consumer-facing materials acknowledge that most states require a VCPR before veterinarians can diagnose and prescribe, that some states allow it to be formed remotely, and that in states that do not, its clinicians may be limited to general advice and non-prescription options. The company presents that as a state-law access problem. Organized veterinary medicine has generally framed it as a patient safety and standard-of-care issue, especially where diagnosis, prescribing, or follow-up accountability are involved. (help.dutch.com)
Industry reaction has been split for some time. Telehealth advocates, including companies and policy groups aligned with virtual care expansion, argue that remote access can help address workforce shortages, wait times, and affordability. Opponents, including AVMA and many state associations, have argued that virtual-first prescribing without adequate examination risks missed diagnoses, fragmented care, and regulatory confusion. Even states that have loosened telemedicine rules have often done so with guardrails. Ohio’s 2025 law, for example, allowed more virtual treatment without a prior in-person exam, but included limits on prescription duration, food-animal use, and licensure. (aaha.org)
Why it matters: For veterinary professionals, the immediate issue is reputational as much as regulatory. A high-profile media figure is now translating a technical VCPR debate into a consumer message that professional groups are protecting incumbents and inflating prices. That may resonate with pet parents already frustrated by access problems and rising bills. But for clinics, the operational reality is still the same: telemedicine can extend care, improve follow-up, support triage, and create efficiency, yet diagnosis and prescribing remain bounded by state practice acts, board rules, and federal drug law. Practices that don’t explain that clearly risk losing trust to platforms that market convenience more simply. (aaha.org)
There’s also a workforce and competitive dimension. Venture-backed telehealth companies are not just arguing for broader access; they’re trying to reshape where routine care begins, who controls the client relationship, and how prescription revenue flows. If public pressure accelerates legislative change in more states, brick-and-mortar practices may need stronger telehealth strategies of their own, both to meet pet parent expectations and to avoid ceding low-acuity cases, chronic-condition follow-up, and client communication to third-party platforms. That is an inference based on the regulatory trend lines and the business models now in market. (paulickreport.com)
What to watch: The next phase is likely to play out in statehouses and veterinary boards, not just in media clips. Watch for new virtual VCPR bills, more explicit prescribing guardrails, and a sharper response from AVMA, AAHA, state VMAs, and practice groups as telemedicine companies keep making their case directly to pet parents. (aavsb.org)